From: SMAD4 - Molecular gladiator of the TGF-β signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRASproto-oncogene
SMAD4Status
Wild N = 70
Mutant M = 16
OR; P Value; CI (95%)
KRAS Status
Wild; n = 65
60 (92.3%)
5 (7.7%)
0.07; 0.00003; 0.021- 0.26
Mutant; n = 21
10 (47.6%)
11(52.4%)